Nicholas Investment Partners’s DA32 Life Science Tech Acquisition Corp. Class A Common Stock DALS Stock Holding History

Nicholas Investment Partners’s Portfolio DALS Stock Details DALS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-200,000	Closed	-$2.05M	–	214
2023 Q2	$2.05M	Hold	200,000	–	–	0.14%	136
2023 Q1	$2.02M	Hold	200,000	–	–	0.15%	128
2022 Q4	$1.98M	Hold	200,000	–	–	0.17%	122
2022 Q3	$1.94M	Hold	200,000	–	–	0.18%	124
2022 Q2	$1.94M	Hold	200,000	–	–	0.18%	128
2022 Q1	$1.95M	Hold	200,000	–	–	0.14%	149
2021 Q4	$1.96M	Hold	200,000	–	–	0.12%	160
2021 Q3	$1.97M	Buy	+200,000	New	+$1.98M	0.14%	152

Nicholas Investment Partners's DALS Position: Q3 2023 in Review

Nicholas Investment Partners sold out of DA32 Life Science Tech Acquisition Corp. Class A Common Stock (DALS) in Q3 2023, closing a stake of 200,000 shares — an estimated $2.05M sold.

Nicholas Investment Partners first reported a position in DALS in Q3 2021 and held it in 8 quarters. The position peaked at $2.05M in Q2 2023. 0 funds tracked by Wall St. Rank hold DALS as of Q3 2023.

Nicholas Investment Partners reported no remaining DA32 Life Science Tech Acquisition Corp. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
Nicholas Investment Partners sold 200,000 DA32 Life Science Tech Acquisition Corp. Class A Common Stock shares in Q3 2023, an estimated $2.05M.
Nicholas Investment Partners first reported a position in DA32 Life Science Tech Acquisition Corp. Class A Common Stock in Q3 2021 and held it in 8 quarters.
Nicholas Investment Partners's DA32 Life Science Tech Acquisition Corp. Class A Common Stock position peaked at $2.05M in Q2 2023.
0 funds tracked by Wall St. Rank held DA32 Life Science Tech Acquisition Corp. Class A Common Stock as of Q3 2023.

Based on Nicholas Investment Partners's 13F filing for Q3 2023, filed 13 Nov 2023.